A recent study using bioinformatics analysis indicated a higher level of SNHG1 in patients with RRMS in relation to the controls and suggested a possible role for SNHG1 in the pathogenesis of MS through an associated competing endogenous RNA axis [31]. This evidence concerns the gene SNHG1 and myeloid sarcoma.